RE:RE:RE:RE:Dose escalationThat will depend on the quality of the results if they are good. In other words, how good will it be. If results are at the level of a real breakthrough therapy, a game changer in cancer treatment like they claim it has the potential to achieve as a best case scenario, then this thing will promote itself. The news of these results will make headlines. If the results are good, but kind of mildly good, like we see positive signs, but we need a trial on more patients selected for sortilin overexpression, then I agree, they will need to promote them.
SPCEO1 wrote: but would add the corrollary that all substance and minimal promotion leads to a sub-standard result. While not a scientist like yourself, I am research based and have had a historical disdain for promotion myself. But it does help optimize a good situation when done well.